Both PD-1 (HR = 0.39, 95% CI 0.22-0.69) and PD-L1 (HR = 0.75, 95% CI, 0.64-0.87) were associated with improved PFS in lung cancer patients undergoing radiation therapy. Here, CD274 is linked to lung cancer.